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Introduction
Pay for Performance (P4P): Models which offer fiscal
incentives to medical and behavioral health providers for
meeting specific expectations related to patient care have
gained popularity over the last decade as a means of
improving quality of care (Bremer et al., 2008).
Research by McLellan et al. (2008) has supported the
feasibility of implementing such programs and the
openness of substance abuse treatment facilities to
participating in P4P.
Treatment Retention: P4P is based on the assumption
that use of a financial reward will promote greater
provider attention to patient attendance thereby
improving outcomes (Roux et al., 2009). To date,
studies examining retention rates following
implementation of P4P strategies have yielded equivocal
results (Brucker & Stewart, 2011; Vandrey et al., 2011).
Factors Influencing Treatment Outcomes: Numerous
barriers to treatment engagement exist and include a) the
presence of a co-morbid psychiatric disorder such as
depression or anxiety, b) the existence of a chronic
medical condition such as HIV or Hepatitis-C, and c) a
history of trauma. Bogenschutz and Siegfried (1998)
observed that a dually diagnosed population attended an
average of only 34% of scheduled outpatient sessions.
Chronic medical conditions have also been cited as a
risk factor for poorer treatment outcomes, especially for
women (Comfort et al., 2003). The issue of trauma is
also of significance, with findings indicating that
patients with a trauma history or PTSD not faring as
well as individuals without such a history (Brown et al.,
1996; Saladin et al., 1995). Hien et al. (2000) observed
that a medication assisted treatment population with a
history of PTSD evinced significantly worse early
treatment (i.e., first three months) outcomes (positive
urine drug screens).
P4P in Philadelphia: Pay for performance criteria were
introduced into the Philadelphia Behavioral Health
System in 2012. Providers meeting prescribed
engagement criteria are eligible for an end of year
payment. While there is anecdotal evidence within the
system that the introduction of these P4P criteria have
led to improved provider attention to early engagement,
evaluation data are scarce.
In response, the present study was conducted to assess
whether individuals meeting early engagement criteria
proposed by Philadelphia’s Community Behavioral
Health (a Medicaid HMO for behavioral health)
demonstrated better outcomes as measured by urine drug
screen results obtained at six and 12 months postintensive outpatient (IOP) initiation.
Hypothesis 1: Patients who met the two early
engagement criteria at 14 days (4 or more days of
service) will demonstrate better outcomes as measured
by urine results obtained at six and 12 months post-IOP
initiation.
Hypothesis 2: Patients who met the two early
engagement criteria at 30 days (8 or more days of
services) will demonstrate better outcomes as measured
by urine results obtained at six and 12 months post-IOP
initiation.

Method

Results (continued)

The data for these analyses were drawn from 76 consecutive
admissions to medication assisted treatment for opiate
dependence who, following assessment, were referred to the
intensive outpatient level of care. The IOP level of care
carries an expectation of nine hours of attendance per week
for a period of minimally 16 weeks. Seventeen of these 76
individuals (30.3%) did not receive any IOP services in the
30 days following their assignment. To allow for the most
complete analysis, these individuals were designated as not
having met the P4P criteria.

Hypothesis 1: As can be seen in Table 1, participants
meeting the 14 day P4P criteria (minimally 4 days of
service) were no less likely to be using opiates at 6 months
(46.3%) than those who did not (35.3%), x2 = .64, p = ns.

The P4P criteria for the intensive outpatient level of care are
the delivery of four days of service within the first 14 days of
treatment and the delivery of eight days of service within the
first 30 days of treatment.

Hypothesis 2: With respect to Hypothesis 2, we observed
minimal beneficial effect of having met the 30 day P4P
criteria. Specifically, individuals with 8 or more services
were no less likely to be using opiates at six months
(46.2%) than those who did not (36.8%), x2 = .491, p =
ns.

Attendance information and urine drug screen results were
extracted from the clinical record. The proportion of urine
drug screens positive for opioids served as the primary
outcome measure. A series of analyses crossing P4P 14 and
30 day criteria-met status and urine results for opioid use at
six and 12 months were conducted.

Hypothesis 1A: As can be seen in Table 1, participants
meeting the 14 day P4P criteria (minimally 4 days of
service) were no less likely to be using opiates at 12
months (37%) than those who did not (41.2%), x2 = .64, p
= ns.

Hypothesis 2A: Similar effects were observed for 12
month urinalysis results; individuals who met 30 day P4P
criteria were no less likely to be using opiates at 12
months (38.5%) than those who did not (36.8%), x2 = .
015, p = ns.

Outcome Measure
Discussion

• Urine Drug Screens for Opioids

Results
Subjects were primarily male (58%) and White (72%). The
average admission age was 40.29+10.79 years. In general,
participants were not treatment naïve (67%). Intravenous use
of opioids was the most common route of administration
(62%) and mean years of opioid use were 13.65+8.04. Table
1 displays the number of cases meeting the IOP P4P criteria
at 14 and 30 days post IOP initiation. Three quarters of the
cases met the insurer established P4P criteria at 14 and 30
days post treatment initiation.
Table 1.

P4P + 14

P4P +

6 months

12
months

N

59

46.3%

37.0%

71

This study represents one of the first attempts at
evaluating the effect of fulfillment of P4P criteria on illicit
opiate use in a medication assisted treatment population.
The assumption was that increased patient contact with the
environment of care would lead to increased motivation
for treatment and therefore, decreased substance use.
Interestingly, the results did not support these hypotheses
around the impact of engagement on substance use.
Previous research (Roux et al., 2009) has supported P4P’s
role in improved outcome, particularly as a result of
increased provider attention to patient attendance. One
possible explanation for the absence of a relationship is
that early engagement in group and individual therapy,
while undeniably positive steps in the recovery process,
ultimately are not directly linked to dose increases/
stabilization on methadone. Future research should focus
on methods that not only promote regular attendance but
also expedite methadone stabilization.
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